Related references
Note: Only part of the references are listed.European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
Joffrey van Prehn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection
Jiahe Chen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Impact of Clostridium difficile infection on pediatric appendicitis
Felix Orelaru et al.
PEDIATRIC SURGERY INTERNATIONAL (2021)
Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children
Larry K. Kociolek et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2021)
Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients
Ruba Barbar et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)
Antibiotic Therapies for Clostridioides difficile Infection in Children
Anne J. Gonzales-Luna et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2021)
Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children
Maribeth R. Nicholson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE)
Joshua Wolf et al.
CLINICAL INFECTIOUS DISEASES (2020)
Moving the Needle on Clostridioides difficile Research in Children: A Major Step Forward but Challenges Remain
Larry K. Kociolek
CLINICAL INFECTIOUS DISEASES (2020)
Does oral vancomycin use necessitate therapeutic drug monitoring?
Nevio Cimolai
INFECTION (2020)
A multicenter study to define the epidemiology and outcomes ofClostridioides difficileinfection in pediatric hematopoietic cell and solid organ transplant recipients
Erick F. Mayer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
Kerrie Davies et al.
ANAEROBE (2020)
Epidemiology and Risk Factors for Community Associated Clostridioides difficile in Children
Margot Miranda-Katz et al.
JOURNAL OF PEDIATRICS (2020)
Evaluation of viral co-infections among patients with community-associatedClostridioides difficileinfection
Lauren Korhonen et al.
PLOS ONE (2020)
Faecal microbiota transplantation forClostridioides difficileinfection: Four years' experience of the Netherlands Donor Feces Bank
Elisabeth M. Terveer et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
Clostridium difficile infection after pediatric solid organ transplantation: a practical single-center experience
Christian Breuer et al.
PEDIATRIC NEPHROLOGY (2019)
Mixed Viral-Bacterial Infections and Their Effects on Gut Microbiota and Clinical Illnesses in Children
Shilu Mathew et al.
SCIENTIFIC REPORTS (2019)
Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridiodes difficile Infections
Jianyi Yin et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study
F. Barbut et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
Zev H. Davidovics et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children
Jillian M. Cotter et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2019)
Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial
Molly A. O'Gorman et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2018)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Microbiologic factors affecting Clostridium difficile recurrence
C. H. Chilton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Guidance document for prevention of Clostridium difficile infection in acute healthcare settings
S. Tschudin-Sutter et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
How to: Surveillance of Clostridium difficile infections
M. Krutova et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
The pitfalls of laboratory diagnostics of Clostridium difficile infection
M. Krutova et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Contribution of the FilmArray® Gastrointestinal Panel in the laboratory diagnosis of gastroenteritis in a cohort of children: a two-year prospective study
Adriana Calderaro et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2018)
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial
Benoit Guery et al.
LANCET INFECTIOUS DISEASES (2018)
Clinical and Microbiological Characteristics of Clostridium difficile Infection Among Hospitalized Children in the Netherlands
Sofie M. van Dorp et al.
CLINICAL INFECTIOUS DISEASES (2017)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains
Nicole Stoesser et al.
PLOS ONE (2017)
A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors
A. G. Clooney et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prevot 1938
Paul A. Lawson et al.
ANAEROBE (2016)
European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection
M. J. T. Crobach et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013
K. A. Davies et al.
EUROSURVEILLANCE (2016)
Molecular characterisation of Czech Clostridium difficile isolates collected in 2013-2015
M. Krutova et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature
H. de Graaf et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons
Lutz von Mueller et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole
Brittany B. Lewis et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
High Colonization Rate and Prolonged Shedding of Clostridium difficile in Pediatric Oncology Patients
Samuel R. Dominguez et al.
CLINICAL INFECTIOUS DISEASES (2014)
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2014)
Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study
M. P. M. Hensgens et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection
S. B. Debast et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014
Alfredo Guarino et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)
Clostridium difficile Infection Among Children Across Diverse US Geographic Locations
Joyanna M. Wendt et al.
PEDIATRICS (2014)
Distinguishing Community-Associated From Hospital-Associated Clostridium difficile Infections in Children: Implications for Public Health Surveillance
Sarah Tschudin-Sutter et al.
CLINICAL INFECTIOUS DISEASES (2013)
The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study
Sahil Khanna et al.
CLINICAL INFECTIOUS DISEASES (2013)
Viral Co-infections Are Common and Are Associated With Higher Bacterial Burden in Children With Clostridium difficile Infection
Rana E. El Feghaly et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2013)
Clostridium difficile Infection in Infants and Children
Gordon E. Schutze et al.
PEDIATRICS (2013)
Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole
Turki Abujamel et al.
PLOS ONE (2013)
The Impact of the Gut Microbiota on Human Health: An Integrative View
Jose C. Clemente et al.
CELL (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Risk Factors and Outcomes Associated With Severe Clostridium difficile Infection in Children
Jason Kim et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Epidemiology and Risk Factors for Clostridium difficile Infection in Children
Thomas J. Sandora et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Share Paper
